VRCA Verrica Pharmaceuticals Inc.

Fundamentals / CIK 0001660334 / USD

Verrica Pharmaceuticals Inc. reported $22.89M in revenue and a net loss of $43.32M for the trailing twelve months ended September 30, 2026 (down 51.8% year over year), with a -184.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VRCA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$43.15M$21.58M$0-$74.63MFY 2017 Net Income: -$4.46M2017FY 2018 Net Income: -$20.65M2018FY 2019 Net Income: -$28.21M2019FY 2020 Net Income: -$42.69M2020FY 2021 Revenue: $12.00MFY 2021 Net Income: -$35.08M2021FY 2022 Revenue: $9.03MFY 2022 Net Income: -$24.49M2022FY 2023 Revenue: $5.12MFY 2023 Net Income: -$67.00M2023FY 2024 Revenue: $7.57MFY 2024 Net Income: -$76.58M2024FY 2025 Revenue: $35.58MFY 2025 Net Income: -$17.89M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $35.58M $7.57M $5.12M $9.03M $12.00M -- -- -- --
Cost of Revenue -- $2.60M $500K -- -- -- -- -- --
Gross Profit -- $4.97M $4.62M -- -- -- -- -- --
Research & Development $8.86M $11.84M $20.30M $12.20M $15.93M $15.67M $15.44M $12.83M $3.73M
Selling, General & Admin $35.22M $58.82M $47.30M $17.41M -- -- -- -- --
Total Operating Expenses $47.76M $73.48M $70.88M $30.33M $42.91M $40.18M $30.08M $21.88M $4.46M
Operating Income -$12.19M -$65.92M -$65.76M -$21.30M -$30.91M -$40.18M -$30.08M -$21.88M -$4.46M
EBITDA -$12.05M -$65.58M -$65.23M -$20.84M -$30.66M -$40.14M -$30.02M -$21.86M --
Interest Income $929K $1.42M $2.74M $476K $123K $521K $1.88M $1.23M --
Interest Expense $7.74M $9.41M $3.96M $2.17M $4.29M $3.03M -- -- --
Income Tax Expense $0 $0 $0 $0 -- -- -- -- --
Net Income -$17.89M -$76.58M -$67.00M -$24.49M -$35.08M -$42.69M -$28.21M -$20.65M -$4.46M
Basic EPS -$1.68 -$14.78 -$14.80 -$7.20 -$13.00 -$17.10 -$11.30 -$14.10 -$15.60
Diluted EPS -$1.68 -$14.78 -$14.80 -$7.20 -$13.00 -$17.10 -$11.30 -$14.10 -$15.60
Basic Shares Outstanding 10.7M 5.2M 4.5M 3.4M 2.7M 2.5M 2.5M 1.5M 285.0K
Diluted Shares Outstanding 10.7M 5.2M 4.5M 3.4M 2.7M 2.5M 2.5M 1.5M 285.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $6.91M $5.86M $5.02M $5.09M $14.34M $12.70M $3.44M $344K
Cost of Revenue -- -- -- -- -- -- $700K $800K
Gross Profit -- -- -- -- -- -- $2.74M -$456K
Research & Development $7.58M $6.03M $3.86M $2.52M $2.21M $1.85M $2.28M $1.17M
Selling, General & Admin $10.36M $10.35M $9.99M $8.12M $9.40M $8.85M $8.85M $9.88M
Total Operating Expenses $19.08M $18.96M $14.74M $12.28M $12.72M $11.19M $11.57M $11.75M
Operating Income -$12.17M -$13.10M -$9.71M -$7.19M $1.63M $1.51M -$8.13M -$11.41M
EBITDA -$12.16M -$13.08M -$9.70M -$7.18M $1.65M $1.55M -$8.08M -$11.36M
Interest Income $45K $111K $201K $205K $159K $228K $337K $205K
Interest Expense $285K $164K $160K $1.31M $2.09M $2.13M $2.20M $2.35M
Net Income -$12.41M -$13.15M -$9.68M -$8.07M -$274K $204K -$9.74M -$16.20M
Basic EPS -$0.58 -$0.62 -$0.45 -- -$0.03 $0.02 -$1.03 --
Diluted EPS -$0.58 -$0.62 -$0.45 -- -$0.03 $0.02 -$1.03 --
Basic Shares Outstanding 21.3M 21.3M 21.3M -- 9.5M 9.5M 9.5M --
Diluted Shares Outstanding 21.3M 21.3M 21.3M -- 9.5M 9.5M 9.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $30.15M $46.33M $69.55M $34.27M $15.75M $10.69M $9.24M $10.27M $8.66M
Short-Term Investments -- -- -- $0 $0 -- -- -- --
Cash & Short-Term Investments $30.15M $10.00M $69.55M $34.27M $70.40M $10.69M $9.24M $10.27M $8.66M
Accounts Receivable, Net $5.26M $48K $4.25M $0 -- -- -- -- --
Inventory $2.24M $2.46M $1.02M $0 -- -- -- -- --
Total Current Assets $42.54M $51.18M $77.53M $39.12M $74.33M $67.65M $64.98M $91.15M $9.08M
Property, Plant & Equipment, Net $209K $589K $1.05M $3.89M $3.89M $3.10M $2.09M $255K --
Other Non-Current Assets $376K $376K $452K $276K $295K $1.57M $1.24M -- --
Total Non-Current Assets $4.59M $2.96M $4.07M $5.61M $5.80M $6.50M $3.44M $754K $0
Total Assets $47.13M $54.13M $81.60M $44.72M $80.12M $74.15M $68.42M $91.91M $9.08M
Accounts Payable $2.07M $1.90M $2.46M $507K $845K $348K $1.19M $922K $153K
Short-Term Debt $0 $12.94M $0 $0 $41.69M $35.31M -- -- --
Deferred Revenue (Current) $782K $0 -- -- -- $500K -- -- --
Other Current Liabilities $119K $105K $244K $0 -- -- -- -- --
Total Current Liabilities $16.44M $29.01M $17.02M $3.46M $46.05M $39.48M $3.35M $2.48M $616K
Long-Term Debt $0 $18.05M $42.87M -- -- -- -- -- --
Total Non-Current Liabilities $5.95M $34.98M $44.81M $1.23M $1.47M $1.69M $58K $0 $0
Total Liabilities $22.39M $63.99M $61.83M $4.69M $47.52M $41.17M $3.41M $2.48M $616K
Total Debt (incl. Leases) $1.63M $33.00M $45.51M $1.53M $43.41M $37.21M $188K -- --
Common Stock $2.0K $1.0K $4.0K $4.0K $3.0K $3.0K $3.0K $3.0K --
Retained Earnings -$324.9M -$307.0M -$230.4M -$163.5M -$139.0M -$103.9M -$61.19M -$33.08M -$12.44M
Accumulated Other Comp. Income -- -- -- $0 -$29K $1.0K $20K -$17K --
Total Stockholders' Equity $24.74M -$9.86M $19.76M $40.03M $32.60M $32.99M $65.02M $89.43M -$7.04M
Total Equity $24.74M -$9.86M $19.76M $40.03M $32.60M $32.99M $65.02M $89.43M -$7.04M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $14.39M $11.20M $20.60M $30.15M $21.10M $15.40M $29.59M $46.33M
Cash & Short-Term Investments $14.39M $11.20M $20.60M $30.15M $21.10M $15.40M $10.00M $10.00M
Accounts Receivable, Net $11.24M $10.94M $7.72M $5.26M $7.05M $9.19M $5.61M $48K
Inventory $2.80M $2.71M $1.97M $2.24M $2.30M $2.52M $2.46M $2.46M
Total Current Assets $36.40M $32.64M $34.13M $42.54M $36.27M $36.78M $39.47M $51.18M
Property, Plant & Equipment, Net $167K $177K $191K $209K $225K $315K $537K $589K
Other Non-Current Assets $638K $638K $640K $376K $376K $376K $376K $376K
Total Non-Current Assets $3.46M $3.38M $4.66M $4.59M $4.62M $2.33M $2.70M $2.96M
Total Assets $39.86M $36.02M $38.79M $47.13M $40.90M $39.11M $42.18M $54.13M
Accounts Payable $1.29M $1.60M $2.19M $2.07M $1.58M $2.32M $1.44M $1.90M
Short-Term Debt -- -- -- $0 $12.46M $12.67M $12.82M $12.94M
Deferred Revenue (Current) $1.10M $1.33M $1.03M $782K $1.56M $481K -- $0
Other Current Liabilities $33K $180K $200K $119K $59K $366K $166K $105K
Total Current Liabilities $21.93M $22.44M $16.22M $16.44M $28.91M $29.22M $29.40M $29.01M
Long-Term Debt -- -- -- $0 $9.16M $11.90M $14.99M $18.05M
Total Non-Current Liabilities $23.91M $9.27M $6.51M $5.95M $29.03M $27.37M $31.36M $34.98M
Total Liabilities $45.84M $31.71M $22.73M $22.39M $57.94M $56.59M $60.75M $63.99M
Total Debt (incl. Leases) $1.67M $1.81M $1.44M $1.63M $23.28M $26.22M $29.61M $33.00M
Common Stock $2.0K $2.0K $2.0K $2.0K $1.0K $1.0K $9.0K $1.0K
Retained Earnings -$360.2M -$347.7M -$334.6M -$324.9M -$316.8M -$316.6M -$316.8M -$307.0M
Total Stockholders' Equity -$5.97M $4.31M $16.05M $24.74M -$17.04M -$17.48M -$18.58M -$9.86M
Total Equity -$5.97M $4.31M $16.05M $24.74M -$17.04M -$17.48M -$18.58M -$9.86M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$17.89M -$76.58M -$67.00M -$24.49M -$35.08M -$42.69M -$28.21M -$20.65M -$4.46M
Depreciation & Amortization $133K $342K $530K $454K $244K $43K $64K $20K --
Stock-Based Compensation $3.32M $7.16M $14.38M $4.99M $6.05M $9.82M $3.33M $2.25M $82K
Change in Receivables -$5.21M $4.20M -$3.86M $0 -- -- -- -- --
Change in Payables $176K -$568K $2.20M -$338K $497K -$838K $263K $769K $86K
Operating Cash Flow -$17.63M -$60.93M -$38.58M -$18.65M -$27.58M -$30.21M -$27.41M -$17.87M -$4.58M
Capital Expenditure $0 -$27K -$362K -$302K -$883K -$1.47M -$682K -$774K --
Free Cash Flow -$17.63M -$60.95M -$38.94M -$18.95M -$28.46M -$31.68M -$28.09M -$18.65M --
Purchases of Investments -- -- $0 -$4.49M -$68.91M -$71.74M -$89.85M -$79.12M --
Investing Cash Flow $0 -$19K -$362K $54.04M -$998K -$3.58M $25.95M -$79.89M --
Common Stock Issued -- -- -- $26.90M $28.12M -- -- -- --
Financing Cash Flow $1.45M $37.73M $74.21M -$16.87M $33.65M $35.23M $423K $99.38M $12.72M
Net Change in Cash -$16.18M -$23.22M $35.27M $18.52M $5.07M $1.45M -$1.03M $1.61M $8.14M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$12.41M -$13.15M -$9.68M -$8.07M -$274K $204K -$9.74M -$16.20M
Depreciation & Amortization $10K $15K $17K $14K $22K $45K $52K $54K
Stock-Based Compensation $1.91M $1.21M $897K $686K $718K $888K $1.03M $756K
Change in Receivables -$299K -$3.21M -$2.46M $1.79M $2.15M -$3.59M -$5.56M -$201K
Change in Inventory -$92K -$738K $262K -- $218K -$59K $0 --
Change in Payables -$529K -$590K $121K $487K -$736K $878K -$453K $931K
Operating Cash Flow -$9.04M -$9.28M -$9.16M -$4.59M $9.69M -$10.04M -$12.68M -$16.06M
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$16.06M
Investing Cash Flow $0 $0 $0 $0 $0 $0 $0 $8.0K
Financing Cash Flow $12.23M -$126K -$120K $13.64M -$3.98M -$4.16M -$4.06M $39.43M
Net Change in Cash $3.20M -$9.40M -$9.28M $9.05M $5.70M -$14.20M -$16.73M $23.37M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- 65.6% 90.2% -- -- -- -- -- --
Operating Margin -34.2% -871.3% -1283.4% -235.8% -257.6% -- -- -- --
Net Profit Margin -50.3% -1012.1% -1307.5% -271.1% -292.3% -- -- -- --
Return on Equity (ROE) -72.3% -- -339.0% -61.2% -107.6% -129.4% -43.4% -23.1% --
Return on Assets (ROA) -37.9% -141.5% -82.1% -54.8% -43.8% -57.6% -41.2% -22.5% -49.1%
Current Ratio 2.59x 1.76x 4.55x 11.31x 1.61x 1.71x 19.39x 36.80x 14.75x
Quick Ratio 2.45x 1.68x 4.49x 11.31x 1.53x 0.27x 2.76x 4.15x 14.06x
Debt to Equity 0.07x -- 2.30x 0.04x 1.33x 1.13x 0.00x -- --
Revenue Growth (YoY) +370.2% +47.7% -43.3% -24.7% -- -- -- -- --
Gross Profit Growth (YoY) -- +7.4% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- -- -- -- 63.8% 65.6%
Operating Margin -184.2% -93.6% -37.1% -34.2% -53.2% -263.4% -772.4% -871.3%
Net Profit Margin -189.2% -102.8% -48.0% -50.3% -84.4% -330.5% -919.2% -1012.1%
Return on Equity (ROE) -- -724.0% -111.0% -72.3% -- -- -- --
Return on Assets (ROA) -108.7% -86.6% -46.0% -37.9% -63.6% -124.3% -156.5% -141.5%
Current Ratio 1.66x 1.45x 2.10x 2.59x 1.25x 1.26x 1.34x 1.76x
Quick Ratio 1.53x 1.33x 1.98x 2.45x 1.18x 1.17x 1.26x 1.68x
Debt to Equity -- 0.42x 0.09x 0.07x -- -- -- --
Revenue Growth (YoY) -51.8% -53.8% +46.1% +1380.2% -- +145.4% -10.1% -82.7%
Gross Profit Growth (YoY) -- -- -- -- -- -- -12.4% --
Operating Income Growth (YoY) -847.8% -967.4% -- -- -- -- -- --
Net Income Growth (YoY) -- -6547.5% -- -- -- -- -- --
EPS Growth (YoY) -- -3200.0% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -193.3% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001660334) · from March 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal